-
Infection and Drug Resistance
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Effect of long-term treatment with eyedrops for glaucoma on conjunctival bacterial flora
Original Research
(855) Views (145) Full article downloads
Authors: Honda R, Toshida H, Suto C, Fujimaki T, Kimura T, Ohta T, Murakami A
Published Date October 2011
Volume 2011:4 Pages 191 - 196
DOI: http://dx.doi.org/10.2147/IDR.S24250
Rio Honda1, Hiroshi Toshida1, Chikako Suto2, Takuro Fujimaki2, Tairo Kimura2, Toshihiko Ohta1, Akira Murakami21Department of Ophthalmology, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, 2Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan
Objective: The effect of eyedrops for glaucoma on conjunctival bacterial flora was investigated by comparing a group of patients treated with such eyedrops for at least 1 year to a control group that did not use eyedrops.
Methods: In both groups, bacterial culture came from scrapings of the conjunctival sac, and the bacterial infection rate and pattern of drug resistance were determined. Findings were analyzed in various subgroups stratified by age, frequency of instillation, and concentration of antiseptic benzalkonium chloride in the eyedrops.
Results: The culture-positive rate was significantly lower in the glaucoma eyedrop group (43/119 eyes, 40.3%) than in the control group (19/28 eyes, 67.8%) (P < 0.05). No differences in infection rate were found among the different age groups. The most frequent bacteria in both groups was coagulase-negative staphylococci. Gram-negative bacteria were only detected in the glaucoma eyedrop group. Retrospective evaluation was possible for 86 eyes of patients from the glaucoma eyedrop group, among which 45 eyes (52.3%) showed some corneal epithelium damage. There was no difference in the culture-positive rate of bacteria between patients who used eyedrops containing 0.01% or higher dose of benzalkonium chloride and those containing less than 0.01%. Strains that showed resistance to levofloxacin were significantly less frequent in the glaucoma eyedrop group (six strains, 15.0%) than in the control group (11 strains, 39.3%) (P < 0.05).
Conclusion: Patients using eyedrops for glaucoma had a lower culture-positive rate of bacteria in the conjunctival sac, probably due to being washed out by the eyedrops. However, Gram-negative bacteria were detected in the eyedrop group. Bacteria isolated from the eyedrop group had lower resistance to levofloxacin, a finding that may have clinical relevance.
Keywords: glaucoma, eyedrop, benzalkonium chloride, conjunctival flora, levofloxacin
Other articles by Dr Hiroshi Toshida
Conjunctival sac bacterial flora isolated prior to cataract surgery
Multipurpose soft contact lens care in Japan
Readers of this article also read:
Comparison of Goldmann and Pascal tonometry in relation to corneal hysteresis and central corneal thickness in nonglaucomatous eyes
Review of oral cholera vaccines: efficacy in young children
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran
A necrotic lung ball caused by co-infection with Candida and Streptococcus pneumoniae
Resistance to antimicrobial drugs in Ghana
Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?
Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
- Treatment of drug-resistant tuberculosis
- Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome
- High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India




